A important advancement in diabetes care is emerging with the approval of tirzepatide at a dosage of 45mg. This innovative formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://nanarcqm267806.bmswiki.com/6028781/significant_development_tirzepatide_strength_for_diabetes_regulation